5 studies found for:    Open Studies | "Histoplasmosis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Histoplasmosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Treatment for Presumed Ocular Histoplasmosis
Condition: Ocular Histoplasmosis
Intervention: Drug: aflibercept
2 Unknown  Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis
Condition: Presumed Ocular Histoplasmosis (POHS)
Interventions: Drug: ranibizumab;   Drug: verteporfin
3 Unknown  Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome
Condition: Ocular Histoplasmosis Syndrome
Intervention: Drug: ranibizumab
4 Recruiting Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome
Conditions: Choroidal Neovascularization;   Presumed Ocular Histoplasmosis
Intervention: Drug: EYLEA (Aflibercept) intravitreal injection
5 Recruiting Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Conditions: Choroidal Neovascularization;   Myopia;   Punctate Inner Choroidopathy (PIC);   Multifocal Choroiditis;   Ocular Histoplasmosis Syndrome;   Central Serous Chorioretinopathy (CSC);   Angioid Streaks;   Trauma, or Hereditary Eye Diseases
Interventions: Drug: Bevacizumab (Avastin; Genentech, Inc.);   Drug: Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy

Indicates status has not been verified in more than two years